Enzyme News: Breaking Enzyme News, Comments and Articles. - Page: 4

Clontech Laboratories, Inc. Partners With Rubicon Genomics To Increase Speed And Efficiency Of Sample Preparation For RNA Sequencing

MOUNTAIN VIEW, Calif. and ANN ARBOR, Mich., June 6, 2013 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., and Rubicon Genomics, Inc. announced today that they have partnered to integrate Clontech's SMART technology with Rubicon's ThruPLEX technology to increase the efficiency and quality of RNA sample preparation for a variety of next generation...

BellBrook Labs Launches Four New Turn-Key Methyltransferase Assay Kits

BellBrook Labs, an innovative developer of drug discovery tools, is launching four new Transzyme Methyltransferase Assay kits, which combine the company’s Transcreener HTS assay technology with Reaction Biology’s purified enzymes to provide complete methyltransferase assay solutions for inhibitor high throughput screening (HTS) and profiling. The new Transzyme Methyltransferase Assay Kits for...

Enzyme could be the key to aiding wound healing in diabetic and elderly people

Blocking a crucial enzyme which produces the stress hormone cortisol could lead to improved wound healing. This would be beneficial for patients with diabetes-associated ulcers', elderly patients who have undergone surgery, or those treated for burns...

Natural GMOs Part 169. Co-evolution of genomic parasites and RNA based defences against them have a long, long history.

Small RNAs as Guardians of the Genome"Given the variety of pathogens and parasites that plague every living organism, it is likely that genomic parasites evolved hot on the heels of the emergence of replicating genomes. The deeply conserved use of small RNAs as mechanisms to defend genomes against mobile [DNA] elements points to this being a

Natural GMOs Part 169. Co-evolution of genomic parasites and RNA based defences against them has a long, long history.

Small RNAs as Guardians of the Genome"Given the variety of pathogens and parasites that plague every living organism, it is likely that genomic parasites evolved hot on the heels of the emergence of replicating genomes. The deeply conserved use of small RNAs as mechanisms to defend genomes against mobile [DNA] elements points to this being

Sphere Fluidics: Ramping up Growth to Find the "One in a Billion"!

CAMBRIDGE, England, June 6, 2013 /PRNewswire/ -- Sphere Fluidics Limited has developed unique technology for single cell analysis and characterization and provides proprietary products and novel services for this rapidly-growing market. This enabling approach can find rare variants in large cell populations and Sphere Fluidics has patented novel Cyto-Mine™ technology that permits up to one...

Nuvilex, Inc.'s Cell Encapsulation Could Play Role in Multimodality Treatment of Cancer Patients

NEW YORK, NY -- (Marketwired) -- 06/06/13 -- Nuvilex, Inc. (OTCQB: NVLX) has a technology in its cell encapsulation process that will very likely play some role in the future of oncology. How large that role will be is contingent upon the technology continuing to return solid results when it's put to the test. One such area where the technology has had a chance to prove its worth is in a preclini...

Novel and Improved Methods for Constructing and Analyzing Synallele Libraries

Methods of constructing and analyzing improved synallele libraries of nucleic acid molecules is disclosed. Each nucleic acid molecule in these libraries (i) comprises a different nucleic acid sequence and (ii) encodes a mammalian secreted protein comprising the same amino acid sequence. Synalleles are variants of a gene that have the same amino acid sequence but different DNA sequences. It has...

ACP-501 Shows Promise in Familial LCAT Deficiency

Researchers have, for the first time, successfully replaced the defective enzyme found in this rare inherited disorder, demonstrating safety as well as significant improvements in HDL and markers of renal function. Heartwire

Vertex Announces Presentation of Data at European Cystic Fibrosis Society Conference

- Presentations include data from two Phase 2 studies in people with cystic fibrosis who have two copies of the F508del mutation - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that six abstracts from its cystic fibrosis (CF) program will be presented at the 36th European Cystic Fibrosis Society (ECFS) Conference in Lisbon, Portuga...

Epizyme, Inc. Announces Closing of Initial Public Offering and Full Exercise of Over-Allotment Option

CAMBRIDGE, Mass., June 5, 2013 /PRNewswire/ -- Epizyme, Inc. (NASDAQ: EPZM) today announced the closing of its initial public offering of 5,913,300 shares of its common stock at a public offering price of $15.00 per share, before underwriting discounts, including 771,300 shares of common stock issued upon the exercise in full by the underwriters of their option to purchase additional shares at the...

Plant biology: Good listeners

Two crucial enzymes on the pollen tube of Arabidopsis receive female chemical signals to guide successful sexual reproduction

Proteostasis Therapeutics Receives Funding from The Michael J. Fox Foundation for Parkinson’s Disease Research

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, today announced it has received a significant grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to fund preclinical research for disease-modifying th...

DNA2.0 Introduces Simple, IP-Free©, Scarless Cloning

Electra Vector System™ Developed for One-Tube Universal Cloning Menlo Park, Calif. (PRWEB) June 05, 2013 DNA2.0, the leading bioengineering solutions provider, today introduced the Electra Vector System, a universal cloning system for simple, scarless cloning. The Electra system is completely free from licensing restrictions and provides researchers from a large variety of disciplines a much-ne...

Synageva BioPharma™ to Present at the Goldman Sachs and Wells Fargo Healthcare Conferences

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today announced that Sanj K. Patel, President and Chief Executive Officer, will present at the Goldman Sachs 34th Annual Global Healthcare Conference in Rancho Palos Verdes, CA on Wednesday, June 12, 2013, at 9:20...

Novus Experts to Deliver Technical Presentations at World Pork Expo

ST. LOUIS, June 5, 2013 /PRNewswire/ -- The World Pork Expo in Des Moines, Iowa, offers the opportunity for pork producers and associated industry professionals to come together for three days to discuss a wide range of pork industry topics including animal well-being, business and environmental management, production efficiencies and more. As a company that is firmly committed to delivering...

Precision BioSciences Files Patent Infringement Lawsuit against Lonza Related to GS XceedTM Gene Expression System

Precision BioSciences, Inc., a leader in the field of genome engineering, today announced that it has filed a patent infringement lawsuit against Lonza Group (LONN.VX) and a number of its affiliates in the U.S. District Court for the District of Delaware. The lawsuit seeks a ruling that Lonza’s importation into the United States and the use, offer for sa...

Avanir Pharmaceuticals Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting with FDA

ALISO VIEJO, Calif., June 5, 2013 /PRNewswire/ -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced that the U.S. Food and Drug Administration (FDA) has agreed to an expedited development pathway for their next-generation compound, AVP-786, requiring only a limited pre-clinical package as part of the Investigational New Drug (IND) application.  Upon completion of these preclini...

Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy

BySharon di Stefano:Where others have failed, Rexahn Pharmaceuticals (RNN) is making rapid progress manipulating the elusive cancer fighting Akt-1 pathway in clinical trials for solid tumors. Akt is an enzyme that modifies proteins by altering the biochemical signals they receive in the body, and has been identified as a leading molecular contender to disrupt a route that leads to tumor developmen...

ASCO: Halozyme's pancreatic cancer therapy is safe with chemo combo

Halozyme Therapeutics may have an important pancreatic cancer treatment-boosting agent in its portfolio of therapeutic enzymes, but the San Diego-based company will not know for a year or more whether tumor responses seen in Phase Ib.....

Raw Food Cave Man Diet Back on Menu Thanks to Technology at Biome Eco Stores

Brisbane, Australia, June 05, 2013 --(PR.com)-- It’s taken thousands of years, but eating raw food is back on the menu thanks to modern appliances such as an Excalibur dehydrator that makes it simple to whip up nutrient-dense raw meals at home. A raw food diet is centred on eating raw whole foods that have not been heated above 49 degrees Celsius, a process that raw foodists say destroys m...

Enzyme That Finds Unwanted DNA In Cells Revealed

Two new studies published in Nature recently reveal the structure and mechanism of an enzyme called cGAS that detects DNA found in the wrong place inside mammal cells and triggers an immune response. The researchers believe their findings open av...

Simon & Luke Files First Hepatitis A Lawsuit Against Townsend Farms and Costco Corporation

First Lawsuit Filed in Hepatitis A Outbreak; Simon & Luke File in California on Behalf of Hospitalized Victim: Civil Case No. BC510633, filed in Los Angeles Superior Court on 6/3/2013 (PRWEB) June 04, 2013 Yesterday the Houston-based food safety law firm of Simon & Luke, with co-counsel Gomez & Iagmin, filed the first lawsuit stemming from a multi-state Hepatitis A outbreak linked, ac...

Codexis Appoints Scott Watson as Vice President of Sales and Marketing

Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced the appointment of Scott Watson as Vice President of Sales and Marketing, effective May 2013. Mr. Watson has more than 25 years of experience in sales, marketing and business development, including in the pharmaceutical and f...

MRM Announces Industry First Vegan-Friendly, GMO-Free Nutritional Series

OCEANSIDE, Calif., June 4, 2013 /PRNewswire/ -- Consumers have long trusted MRM to create innovative sports and wellness supplements using high quality ingredients.  With the advent of a plant-based, GMO-free nutritional supplement line, MRM is now poised to address nutritional needs within a rapidly growing consumer segment. (Logo: http://photos.prnewswire.com/prnh/20130604/LA26268LOGO)...